Source link : https://www.newshealth.biz/health-news/fda-approves-expansion-of-treatment-area-for-ak-treatment/
The US Food and Drug Administration has approved a supplemental new drug application for tirbanibulin topical ointment, allowing the expansion of the surface area treated for actinic keratosis (AK) of the face or scalp from 25 cm2 to 100 cm2. Tirbanibulin is a microtubule inhibitor, approved for the topical treatment of AK of the face […]
Author : News Health
Publish date : 2024-06-11 09:12:27
Copyright for syndicated content belongs to the linked Source.